Design of a Reversible Cholinesterase Inhibitor Mamentine HCL Nanogel: Formulation and In-vitro Evaluation
Subhasri Mohapatra, Sourabh Jain & Karunakar Shukla · Journal of Pharmaceutical Research International · 2021
Memantine hydrochloride is a is a reversible cholinesterase inhibitor used in the treatment of Alzheimer’s disease, low-moderate affinity, uncompetitive n-methyl-d-aspartate (NMDA) receptor antagonist, with strong voltage dependency and rapid blocking/unblocking kinetics. The pre...
Open access
Research Article
10.9734/jpri/2021/v33i41B32374